Vito Racanelli

9.3k total citations · 1 hit paper
151 papers, 6.5k citations indexed

About

Vito Racanelli is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Vito Racanelli has authored 151 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 36 papers in Molecular Biology and 36 papers in Oncology. Recurrent topics in Vito Racanelli's work include Multiple Myeloma Research and Treatments (25 papers), Hepatitis C virus research (22 papers) and T-cell and B-cell Immunology (21 papers). Vito Racanelli is often cited by papers focused on Multiple Myeloma Research and Treatments (25 papers), Hepatitis C virus research (22 papers) and T-cell and B-cell Immunology (21 papers). Vito Racanelli collaborates with scholars based in Italy, Iran and United States. Vito Racanelli's co-authors include Barbara Rehermann, Franco Dammacco, Angelo Vacca, Patrizia Leone, Federico Perosa, Marcella Prete, Domenico Sansonno, Antonio Giovanni Solimando, Nicola Silvestris and Eui‐Cheol Shin and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Vito Racanelli

147 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Liver as an Immunological Organ

2006 1.0k citations Vito Racanelli, Barbara Rehermann profile →

Peers

Countries citing papers authored by Vito Racanelli

Since Specialization

Citations

This map shows the geographic impact of Vito Racanelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Racanelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Racanelli more than expected).

Fields of papers citing papers by Vito Racanelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vito Racanelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Racanelli. The network helps show where Vito Racanelli may publish in the future.

Co-authorship network of co-authors of Vito Racanelli

This figure shows the co-authorship network connecting the top 25 collaborators of Vito Racanelli. A scholar is included among the top collaborators of Vito Racanelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vito Racanelli. Vito Racanelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Direct oral anticoagulants in deep vein thrombosis associated with inferior vena cava agenesis: A report of three cases and a systematic review 2024 ·IJC Heart & Vasculature ·(unknown), Vito Racanelli, Nicola Susca, Nicola Martinelli, Alberto Maino	0
2	Predicting Factors of Worse Prognosis in COVID-19: Results from aCross-sectional Study on 52 Inpatients Admitted to the Internal MedicineDepartment 2024 ·Endocrine Metabolic & Immune Disorders - Drug Targets ·Giuseppe Lisco, Antonio Giovanni Solimando, (unknown), Anna De Tullio, (unknown), (unknown), Vito Angelo Giagulli, Marcella Prete, Emilio Jirillo, Annalisa Saracino, Vito Racanelli, Vincenzo Triggiani	1
3	Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations 2024 ·Cancers ·Silvia Casagrande, (unknown), Giovanni Bertalot, Roberto Bortolotti, Vito Racanelli, Orazio Caffo, Bruno Giometto, Alvise Berti, Antonello Veccia	33
4	Non-Classical HLA Class 1b and Hepatocellular Carcinoma 2023 ·Biomedicines ·Vallì De Re, Maria Lina Tornesello, Vito Racanelli, Marcella Prete, Agostino Steffan	2
5	Electrocardiographic Pathological Findings Caused by the SARS-CoV-2 Virus Infection: Evidence from a Retrospective Multicenter International Cohort Longitudinal Pilot Study of 548 Subjects 2023 ·Journal of Cardiovascular Development and Disease ·Nicola Susca, Antonio Giovanni Solimando, Paola Borrelli, (unknown), Francesco Monitillo, Pasquale Raimondo, (unknown), (unknown), Gaetano Brindicci, Mohammad Abumayyaleh, Ibrahim El‐Battrawy, Annalisa Saracino, Salvatore Grasso, Natale Daniele Brunetti, Vito Racanelli, Francesco Santoro	2
6	Single-cell RNA sequencing uncovers heterogeneous transcriptional signatures in tumor-infiltrated dendritic cells in prostate cancer 2023 ·Heliyon ·(unknown), Arezou Khosrojerdi, Mohammad Lotfollahi, (unknown), Mohammad GhasemiGol, (unknown), Mohammad Fereidouni, Mohammad Hossein Rohban, (unknown), (unknown), Patrizia Leone, Nicola Silvestris, Hossein Safarpour, Vito Racanelli	6
7	Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do 2022 ·Cancers ·Concetta Zito, Roberta Manganaro, (unknown), (unknown), Vito Racanelli, Mariacarmela Santarpía, Nicola Silvestris, Scipione Carerj	19
8	Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 2021 ·Journal of Clinical Medicine ·Alessio Buonavoglia, Patrizia Leone, Marcella Prete, Antonio Giovanni Solimando, (unknown), Gianvito Lanave, Michele Camero, Vito Martella, Lorenzo Lo Muzio, Vito Racanelli	12
9	Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine 2021 ·Cancers ·Afshin Derakhshani, Shahryar Hashemzadeh, Zahra Asadzadeh, Mahdi Abdoli Shadbad, (unknown), Hossein Safarpour, (unknown), Antonio Giovanni Solimando, Vito Racanelli, P. Singh, Souzan Najafi, (unknown), Oronzo Brunetti, Nicola Silvestris, Behzad Baradaran	64
10	Arginase 1 (Arg1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy 2021 ·Journal of Clinical Medicine ·Afshin Derakhshani, Nima Hemmat, Zahra Asadzadeh, (unknown), Mahdi Abdoli Shadbad, (unknown), Nicola Silvestris, Vito Racanelli, Behzad Baradaran	34
11	Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection 2021 ·Journal of Clinical Medicine ·(unknown), Afshin Derakhshani, Mohammad GhasemiGol, Mohammad Fereidouni, Ebrahim Miri‐Moghaddam, Behzad Baradaran, (unknown), Souzan Najafi, Antonio Giovanni Solimando, Leigh M. Marsh, Nicola Silvestris, Simona De Summa, Angelo Paradiso, Vito Racanelli, Hossein Safarpour	34
12	Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment 2021 ·Biomedicines ·(unknown), Amir Baghbanzadeh, Afshin Derakhshani, Patrizia Leone, Nicola Silvestris, Vito Racanelli, Antonio Giovanni Solimando, Behzad Baradaran	56
13	Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFNβ-1α, Glatiramer Acetate, and Dimethyl Fumarate Drugs 2021 ·Journal of Personalized Medicine ·Afshin Derakhshani, Zahra Asadzadeh, Hossein Safarpour, Patrizia Leone, Mahdi Abdoli Shadbad, (unknown), Behzad Baradaran, Vito Racanelli	23
14	A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 2021 ·Genes ·Mahdi Abdoli Shadbad, Sahar Safaei, Oronzo Brunetti, Afshin Derakhshani, Parisa Lotfinejad, Ahad Mokhtarzadeh, Nima Hemmat, Vito Racanelli, Antonio Giovanni Solimando, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran	52
15	The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers 2020 ·International Journal of Molecular Sciences ·Omid Kooshkaki, Afshin Derakhshani, Hossein Safarpour, Souzan Najafi, Parviz Vahedi, Oronzo Brunetti, (unknown), Parisa Lotfinejad, Angelo Paradiso, Vito Racanelli, Nicola Silvestris, Behzad Baradaran	28
16	PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases 2020 ·Liver International ·Vallì De Re, Maria Lina Tornesello, Mariangela De Zorzi, Laura Caggiari, Francesca Pezzuto, Patrizia Leone, Vito Racanelli, Gianfranco Lauletta, Stefania Zanussi, Ombretta Repetto, Laura Gragnani, Francesca Maria Rossi, Riccardo Dolcetti, Anna Linda Zignego, Franco M. Buonaguro, Agostino Steffan	4
17	Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 2020 ·International Journal of Molecular Sciences ·Omid Kooshkaki, Afshin Derakhshani, Negar Hosseinkhani, (unknown), Sahar Safaei, Oronzo Brunetti, Vito Racanelli, Nicola Silvestris, Behzad Baradaran	95
18	Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 2018 ·Neoplasia ·Ilaria Saltarella, Maria Antonia Frassanito, Aurelia Lamanuzzi, Arianna Brevi, Patrizia Leone, Vanessa Desantis, Lucia Di Marzo, Matteo Bellone, Daniele Derudas, Doménico Ribatti, Raffaella Chiaramonte, Maria Teresa Palano, Antonino Neri, Maria Addolorata Mariggiò, Ruggiero Fumarulo, Franco Dammacco, Vito Racanelli, Angelo Vacca, Roberto Ria	29
19	A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target 2014 ·Clinical Cancer Research ·(unknown), Michele Moschetta, Maria Antonia Frassanito, Simona Berardi, Ivana Catacchio, Roberto Ria, Vito Racanelli, Antonella Caivano, Antonio Giovanni Solimando, Daniele Vergara, Michele Maffia, Dominga Latorre, Antonia Rizzello, Alfredo Zito, Paolo Ditonno, Eugenio Maiorano, Doménico Ribatti, Angelo Vacca	53
20	Hepatitis C virus mutation affects proteasomal epitope processing 2004 ·Journal of Clinical Investigation ·Ulrike Seifert, H. Liermann, Vito Racanelli, Anne Halenius, Manfred Wiese, Heiner Wedemeyer, Thomas Ruppert, Kay Rispeter, Peter Henklein, Alice J.A.M. Sijts, Hartmut Hengel, Peter‐M. Kloetzel, Barbara Rehermann	116

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact